Back to Search
JOHN ROTROSEN, MD
MD
Psychiatry Physician
NPI: 1801982533Individual
Specialties, Licenses & Credentials
Clinical Trials (4)
4
Linked Trials
0
Recruiting
1
With Results
Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
NCT00015301COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Modeling Impaired Judgement in Cocaine Abusers - 6
NCT00015236COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
NCT02032433COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Sustained-release naltrexone for opioid dependence.
PMID 40342086·Cochrane Database Syst Rev·2025
1-meta
Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.
PMID 38616571·Addiction·2024
8-other
Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
PMID 37712113·Addiction·2024
8-other
Twelve-Month Outcomes for Remitters Following Electroconvulsive Therapy for Depression.
PMID 35452195·J Clin Psychiatry·2022
8-other
Opioid agonist treatment for people who are dependent on pharmaceutical opioids.
PMID 36063082·Cochrane Database Syst Rev·2022
1-meta
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone.
PMID 35452194·J Clin Psychiatry·2022
2-rct
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse.
PMID 34338389·Addiction·2022
2-rct
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.
PMID 35605529·Drug Alcohol Depend·2022
2-rct
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.
PMID 34170188·Am J Psychiatry·2021
4-observational
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
PMID 33771287·J Subst Abuse Treat·2021
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 423 EAST 23 ST, PSYCHIATRY VA NYHHS
NEW YORK, NY 10010 - Phone
- (212) 951-3294
Quick Facts
- NPI
- 1801982533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile